Journal of Clinical Investigation · 2006 · 302 citations · 39 references
Life SciencesImmunologyPathologyImmunopathologyInflammationInnate ImmunityAcute InflammationAcute Lung InjuryImmune-mediated InjuryMammalian ImmunologyNeutrophil BiologyPhagocyte BiologyAcute Lung Injury PathophysiologyEpithelial Barrier PermeabilityFc ReceptorsGranulocyte ResponsesLung Microvascular PermeabilityNeutrophil InvolvementNeutrophil-mediated InjuryPulmonary Fluid Clearance
Transfusion-related acute lung injury (TRALI) is the most common cause of transfusion-related mortality. To explore the pathogenesis of TRALI, we developed an in vivo mouse model based on the passive transfusion of an MHC class I (MHC I) mAb (H2Kd) to mice with the cognate antigen. Transfusion of the MHC I mAb to BALB/c mice produced acute lung injury with increased excess lung water, increased lung vascular and lung epithelial permeability to protein, and decreased alveolar fluid clearance. There was 50% mortality at a 2-hour time point after Ab administration. Pulmonary histology and immunohistochemistry revealed prominent neutrophil sequestration in the lung microvasculature that occurred concomitantly with acute peripheral blood neutropenia, all within 2 hours of administration of the mAb. Depletion of neutrophils by injection of anti-granulocyte mAb Gr-1 protected mice from lung injury following MHC I mAb challenge. FcRgamma-/- mice were resistant to MHC I mAb-induced lung injury, while adoptive transfer of wild-type neutrophils into the FcRgamma-/- animals restored lung injury following MHC I mAb challenge. In conclusion, in a clinically relevant in vivo mouse model of TRALI using an MHC I mAb, the mechanism of lung injury was dependent on neutrophils and their Fc gamma receptors.
39
FcR γ chain deletion results in pleiotrophic effector cell defects
Toshiyuki Takai, Min Li, Diana L. Sylvestre et al. · Cell · 1994 · 968 citations
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
David M. Lee, Daniel S. Friend, Michael F. Gurish et al. · Science · 2002 · 744 citations
Life Sciences, Immunology, Pathology +17